Goldman Sachs
VIGL

Goldman Sachs’s Vigil Neuroscience VIGL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$338K Sell
42,562
-13,004
-23% -$103K ﹤0.01% 4463
2025
Q1
$98.9K Sell
55,566
-201,076
-78% -$358K ﹤0.01% 4821
2024
Q4
$436K Buy
+256,642
New +$436K ﹤0.01% 4367
2024
Q3
Sell
-401,139
Closed -$1.6M 5015
2024
Q2
$1.6M Buy
401,139
+382,900
+2,099% +$1.53M ﹤0.01% 3316
2024
Q1
$62.2K Sell
18,239
-66,861
-79% -$228K ﹤0.01% 4515
2023
Q4
$288K Sell
85,100
-61,102
-42% -$207K ﹤0.01% 4207
2023
Q3
$788K Buy
146,202
+133,194
+1,024% +$718K ﹤0.01% 3661
2023
Q2
$122K Sell
13,008
-11,818
-48% -$111K ﹤0.01% 4531
2023
Q1
$243K Sell
24,826
-48,185
-66% -$472K ﹤0.01% 4442
2022
Q4
$913K Sell
73,011
-13
-0% -$163 ﹤0.01% 3743
2022
Q3
$665K Sell
73,024
-53
-0.1% -$483 ﹤0.01% 4073
2022
Q2
$189K Sell
73,077
-762
-1% -$1.97K ﹤0.01% 4923
2022
Q1
$519K Buy
+73,839
New +$519K ﹤0.01% 4544